Recent Investment Analysts’ Ratings Changes for Welltower (WELL)

A number of firms have modified their ratings and price targets on shares of Welltower (NYSE: WELL) recently:

• 10/29/2026 – Welltower had its “outperform” rating reaffirmed by Raymond James Financial. They now have a $263.00 price target on the stock.
• 10/29/2026 – Welltower had its price target lowered by Cantor Fitzgerald from $260.00 to $258.00. They now have an “overweight” rating on the stock.
• 10/28/2026 – Welltower was downgraded by Weiss Ratings from “buy (b-)” to “hold (c)”.
• 10/28/2026 – Welltower was upgraded by Freedom Broker from “hold” to “buy”. They now have a $255.00 price target on the stock.
• 10/27/2026 – Welltower had its “buy” rating reaffirmed by UBS Group. They now have a $269.00 price target on the stock.
• 10/19/2026 – Welltower had its price target raised by Wells Fargo & Company from $266.00 to $268.00. They now have an “overweight” rating on the stock.
• 10/13/2026 – Welltower had its price target lowered by Barclays from $259.00 to $246.00. They now have an “equal weight” rating on the stock.
• 10/8/2026 – Welltower was upgraded by Weiss Ratings from “hold (c+)” to “buy (b-)”.
• 9/25/2026 – Welltower was upgraded by Jefferies Financial Group to “strong-buy”.
• 9/24/2026 – Welltower was upgraded by JPMorgan Chase & Co. from “neutral” to “overweight”. They now have a $260.00 price target on the stock, up from $230.00.
• 9/21/2026 – Welltower had its “hold (c+)” rating reaffirmed by Weiss Ratings.
• 9/21/2026 – Welltower had its “outperform” rating reaffirmed by Evercore. They now have a $256.00 price target on the stock, down from $260.00.
• 9/15/2026 – Welltower is now covered by Jefferies Financial Group. They set a “buy” rating and a $275.00 price target on the stock.

Welltower Price Performance

Shares of WELL stock traded up $6.70 during trading hours on Wednesday, hitting $247.87. 979,256 shares of the company’s stock were exchanged, compared to its average volume of 3,106,788. Welltower Inc. has a 52 week low of $181.47 and a 52 week high of $255.20. The stock has a market cap of $181.84 billion, a price-to-earnings ratio of 107.30, a price-to-earnings-growth ratio of 1.15 and a beta of 0.79. The company has a debt-to-equity ratio of 0.39, a current ratio of 3.16 and a quick ratio of 3.16. The stock’s 50-day moving average is $233.51 and its 200-day moving average is $218.75.

Welltower (NYSE:WELL) last released its quarterly earnings results on Monday, October 26th. The real estate investment trust reported $1.67 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.64 by $0.03. Welltower had a return on equity of 3.61% and a net margin of 12.08%. The business had revenue of $3.72 billion during the quarter, compared to analysts’ expectations of $3.64 billion. During the same period in the previous year, the business posted $1.34 earnings per share. The firm’s revenue for the quarter was up 38.4% compared to the same quarter last year. As a group, research analysts forecast that Welltower Inc. will post 6.51 EPS for the current year.

Welltower Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Thursday, November 19th. Stockholders of record on Tuesday, November 10th will be paid a dividend of $0.85 per share. This represents a $3.40 annualized dividend and a dividend yield of 1.4%. The ex-dividend date of this dividend is Tuesday, November 10th. Welltower’s dividend payout ratio is 147.19%.

Insider Buying and Selling at Welltower

In related news, Director Andrew Gundlach purchased 5,000 shares of the stock in a transaction that occurred on Wednesday, August 26th. The stock was acquired at an average price of $242.06 per share, with a total value of $1,210,300.00. Following the completion of the acquisition, the director directly owned 30,000 shares in the company, valued at approximately $7,261,800. This trade represents a 20.00% increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Purchased indirectly through two trusts. The transaction was executed in multiple trades at prices ranging from $241.59 to $242.59. The reported $242.06 price is the weighted-average purchase price. 0.37% of the stock is currently owned by corporate insiders.

Welltower Inc (NYSE: WELL) is a healthcare-focused real estate investment trust that owns, develops, and manages properties used to provide healthcare and related services. Its portfolio is centered on senior housing communities, outpatient medical facilities, and post-acute care properties, including assets operated by healthcare providers and senior living companies.

The company’s senior housing investments support independent living, assisted living, and memory care services. Its outpatient medical properties accommodate physicians, clinics, and other healthcare providers, while its broader healthcare real estate portfolio is designed to serve demand for care delivered outside traditional hospitals.